Filing Details
- Accession Number:
- 0001237899-11-000042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-26 16:17:31
- Reporting Period:
- 2011-07-25
- Filing Date:
- 2011-07-26
- Accepted Time:
- 2011-07-26 16:17:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1377247 | Peter Powchik | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-07-25 | 25,000 | $15.64 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-07-25 | 6,949 | $56.26 | 18,051 | No | 4 | F | Direct | |
Common Stock | Disposition | 2011-07-25 | 7,074 | $56.26 | 10,977 | No | 4 | F | Direct | |
Common Stock | Disposition | 2011-07-26 | 3,577 | $55.19 | 7,400 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-07-26 | 7,400 | $54.74 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-07-25 | 25,000 | $0.00 | 25,000 | $15.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
49,428 | 2016-10-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,388 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 3,577 shares of Company stock on July 26, 2011 at prices ranging from $55.00 to $55.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2011 at each separate price.
- Represents volume-weighted average price of sales of 7,400 shares of Company stock on July 26, 2011 at prices ranging from $54.25 to $54.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2011 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case.